Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3C
pubmed:dateCreated
2003-8-20
pubmed:abstractText
The prognosis of patients with carcinoma of unknown primary remains poor with an expected median survival of 6 to 12 months. We evaluated the activity of a chemotherapy regimen combining gemcitabine and docetaxel in patients who primarily failed cisplatin-based chemotherapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0250-7005
pubmed:author
pubmed:issnType
Print
pubmed:volume
23
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2801-4
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed:articleTitle
Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site.
pubmed:affiliation
Centre Régional de Lutte contre le Cancer Val d'Aurelle Montpellier, Parc Euromédecine, 34298-Montpellier, France.
pubmed:publicationType
Journal Article, Clinical Trial